Drugs / Bavarian Nordic smallpox vaccine
last change Jun 2026 re-read 3 minutes ago

Bavarian Nordic smallpox vaccine

Vaccine

Developed for
monkeypox
Investigated by
McMaster University

Trials 1

20252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT05745987 Sep 2024 → Jun 2026 overdue monkeypox McMaster University Recruiting No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Bavarian Nordic smallpox vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT05745987 ↗
Modality Vaccine “smallpox vaccine” NCT05745987 ↗